期刊文献+

紫草素及其衍生物抗妇科肿瘤作用研究进展 被引量:12

Research progress of anti-gynoecological tumors effect of shikonin and its derivatives
原文传递
导出
摘要 紫草素是从传统中药紫草中提取的萘醌类化合物,具有抗炎、抗氧化、抗肿瘤、促进伤口愈合等作用。近年来,紫草素及其衍生物的抗肿瘤作用得到广泛研究。多项体外和体内研究表明紫草素及其衍生物可有效抑制乳腺癌、宫颈癌等妇科恶性肿瘤的发生与发展。从阻滞细胞周期、促进肿瘤细胞凋亡、抑制癌细胞转移和侵袭、诱导自噬和坏死等方面综述近几年紫草素及衍生物在抗妇科肿瘤领域的研究进展,为紫草素类化合物在妇科肿瘤中的临床研究提供参考。 Shikonin is a natural naphthoquinone compound extracted from the traditional Chinese medicine—Lithospermum, and it has anti-inflammatory, antioxidant, anti-tumor, wound healing, and other effects. In recent years, the antitumor effects of shikonin and its derivatives have been studied extensively. Numerous studies in vitro and in vivo showed that shikonin and its derivatives can effectively inhibit the initiation and development of breast cancer, cervical cancer and other gynecological malignancies, the research progress of shikonin in the field of anti-gynecological tumors in recent years was reviewed from the aspects of blocking cell cycle, promoting tumor cell apoptosis, inhibiting cancer cell metastasis and invasion, inducing autophagy and necrosis, etc. It provides a reference for the clinical research of shikonin compounds in gynecological tumors.
作者 陈静 侯尧 伍春莲 CHEN Jing;HOU Yao;WU Chun-lian(Key Laboratory of Southwest Wildlife Resources Conservation of the Ministry of Education,China West Normal University,Nanchong 637009,China;College of Life Science,China West Normal University,Nanchong 637009,China)
出处 《中草药》 CAS CSCD 北大核心 2020年第14期3814-3820,共7页 Chinese Traditional and Herbal Drugs
基金 教育部“春晖计划”合作科研项目(2018-131) 西华师范大学英才科研基金(17YC350) 西华师范大学基本科研业务费(19B038)。
关键词 紫草素 抗肿瘤 乳腺癌 宫颈癌 卵巢癌 子宫内膜癌 shikonin anti-tumor breast cancer cervical cancer ovarian carcinoma endometrial carcinoma
  • 相关文献

参考文献12

二级参考文献89

  • 1Kellert IM, Botterweck AA, Huveneers JA, et al. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003[J]. Eur J Cancer Prey, 2009,18(1) : 85-89.
  • 2Suthipintawong C, Wejaranayang C, Vipupinyo C. Prognostic significaance of ER, PR, Ki67, c-erbB2,and p53 in endometrial carcinoma[J]. J Med Assoc Thai, 2008, 91 (12) :1779- 1784.
  • 3Deroo BJ, Korach KS. Estrogen receptors and human disease [J]. J Clin Invest, 2006,116(3) :561-570.
  • 4Safe SAKK. Non-classical genomic estrogen receptor(ZER)/ specificity protein and ER/activating protein-1 signaling pathways[J]. J Mol Endocrinol, 2008,41 (5) : 263-275.
  • 5Antal MC, Krust A, Chambon P, et al. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant[J]. Proc Natl Acad Sci USA, 2008,105 (7) : 2433-2438.
  • 6Zafrakas M, Kostopoulou E,Dragoumis K, et al. Expression of estrogen receptors alpha and beta in two uterine mesenchymal tumors after prolonged tamoxifen therapy[J]. Eur J Gynaecol Oncol, 2004,25 (4) : 530-533.
  • 7Shao R, Egecioglu E,Weijdegard B, et al. Dynamic regulation of estrogen receptor-alpha isoform expression in the mouse fallopian tube: mechanistic insight into estrogen-dependent production and secretion of insulin-like growth factors [J]. Am J Physiol Endocrinol Metab, 2007,293(5) : 1430-1442.
  • 8Wu H, Chen Y, Liang J, et al. Hypomethylation-linkde activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis[J]. Nature, 2005,438(7070):981-987.
  • 9Chakravarty D, Srinivasan R, Ghosh S, et al. Estrogen receptor beta(ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma[J]. Appl Immunohistochem /Viol Morphol, 2008,16 (6) : 535-542.
  • 10SaegusaM, Okayasu L Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium[J].Jpn J Cancer Res,2000,91(5):510-518.

共引文献92

同被引文献211

引证文献12

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部